HomeInsightsResults

Eris Lifesciences Ltd Quarterly Result

Eris Lifesciences Ltd Quarterly Result

stocks purchased

₹ 0.1 Cr

Volume Transacted

(Nov 22, 2024)

stocks purchased

1.0 K

Stocks Traded

(Nov 22, 2024)

Last Updated on: Nov 23, 2024

Image

ERIS Lifesciences Ltd

NSE: ERIS

Net Profit

₹ 96.35

Last updated on: Nov 23, 2024

Key Highlights

  • The revenue of ERIS Lifesciences Ltd for the Sep '24 is ₹ 745.72 crore as compare to the Jun '24 revenue of ₹ 721.36 crore. This represent the growth of 3.3769526%.
  • The ebitda of ERIS Lifesciences Ltd for the Sep '24 is ₹ 269.06 crore as compare to the Jun '24 ebitda of ₹ 251.63 crore. This represent the growth of 6.926834%.
  • The net profit of ERIS Lifesciences Ltd for the Sep '24 is ₹ 96.35 crore as compare to the Jun '24 net profit of ₹ 89.42 crore. This represent the growth of 7.749944%.

Results Analysis

Market Price of ERIS Lifesciences Ltd

1M

1Y

3Y

5Y

Monitoring ERIS Lifesciences Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
22 Nov 20241376.15
21 Nov 20241365.95
19 Nov 20241364.4
18 Nov 20241356.25
14 Nov 20241353.8
13 Nov 20241328.8
12 Nov 20241367.75
11 Nov 20241324.7
08 Nov 20241303.45
07 Nov 20241302.1

Historical Revenue of ERIS Lifesciences Ltd

No data available

* All values are in crore

Historical EBITDA of ERIS Lifesciences Ltd

No data available

* All values are in crore

Historical Net Profit of ERIS Lifesciences Ltd

No data available

* All values are in crore

ERIS Lifesciences Ltd News Hub

News

Board of Eris Lifesciences approves acquisition of 30% stake in Levim Lifetech

The Board of Eris Lifesciences at its meeting held on 25 October 2024 has approved the exe...

Read more

25 Oct 202418:47

News

ERIS Lifesciences announces board meeting date

ERIS Lifesciences will hold a meeting of the Board of Directors of the Company on 25 Octob...

Read more

22 Oct 202415:56

News

ERIS Lifesciences to convene AGM

ERIS Lifesciences announced that the 18th Annual General Meeting (AGM) of the company will...

Read more

05 Aug 202418:42

News

ERIS Lifesciences announces board meeting date

ERIS Lifesciences will hold a meeting of the Board of Directors of the Company on 2 August...

Read more

31 Jul 202412:40

News

Eris Lifesciences allots 22,492 equity shares under ESOP

Eris Lifesciences has allotted 22,492 equity shares under ESOP on 20 June 2024. The paid u...

Read more

24 Jun 202412:26

News

Board of ERIS Lifesciences approves composite scheme of arrangement

The Board of ERIS Lifesciences at its meeting held on 21 May 2024 has approved composite s...

Read more

21 May 202418:42

Document

Annual Reports

Annual Report 2023

dropdown
download

Credit Ratings

Credit Report 2023

dropdown
download

Concalls

Aug 2024

PPT

June 2024

TranscriptPPT

Mar 2023

Transcript

Jan 2023

PPT

Oct 2022

PPT

Aug 2022

PPT

May 2022

PPT

Feb 2022

PPT

Aug 2021

PPT

July 2021

PPT

May 2021

PPT

Jan 2021

PPT

Nov 2020

PPT

Aug 2020

PPT

June 2020

PPT

Feb 2020

PPT

FAQ's For Eris Lifesciences Ltd Quarterly Result

What is the EPS of ERIS Lifesciences Ltd stock?

The Earnings Per Share (EPS) of ERIS Lifesciences Ltd is 25.6. An EPS is the amount of net income attributed to each share of a common stock.

How is ERIS Lifesciences Ltd EPS calculated?

The EPS of ERIS Lifesciences Ltd is calculated by dividing the net income by the number of outstanding shares. The formula is EPS = (Net Income - Dividends on Preferred Stock) / Average Outstanding Shares.

How often does ERIS Lifesciences Ltd report its EPS?

ERIS Lifesciences Ltd typically reports its EPS quarterly and annually, in conjunction with its financial statements and earnings reports.

What factors can influence ERIS Lifesciences Ltd EPS?

Factors that influence the EPS of ERIS Lifesciences Ltd include revenue changes, cost fluctuations, operational efficiency, tax rates, and one-time gains or losses.

Can ERIS Lifesciences Ltd EPS growth indicate future performance?

Yes, consistent growth in ERIS Lifesciences Ltd EPS can suggest strong financial health and effective management, potentially indicating positive future performance.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199*